Search research articles
Contact Us
Filters
Showing results (451-460 of 628) with videos related to
Page
of 63
Sort By:
Bone Marrow Transplantation
|
July 3, 2003
Use of nonvolume-reduced (unmanipulated after thawing) umbilical cord blood stem cells for allogeneic transplantation results in safe engraftment
T Hahn, U Bunworasate, M C George, et al.
Acta Haematologica
|
January 30, 2019
Relapsed Philadelphia Chromosome-Positive Pre-B-ALL after CD19-Directed CAR-T Cell Therapy Successfully Treated with Combination of Blinatumomab and Ponatinib
Firas El Chaer, Noa G Holtzman, Edward A Sausville, et al.
Blood Advances
|
July 16, 2025
Olutasidenib alone or combined with azacitidine in patients with mutant IDH1 myelodysplastic syndrome
Jorge E Cortes, Jay Yang, Gail J Roboz, et al.
Biomolecules
|
January 8, 2025
Rapid Detection of <i>PML::RARA</i> Fusions in Acute Promyelocytic Leukemia: CRISPR/Cas9 Nanopore Sequencing with Adaptive Sampling
William Middlezong, Victoria Stinnett, Michael Phan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 30, 1999
Patients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered
J C Byrd, R K Dodge, A Carroll, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 14, 2013
Translational phase I trial of vorinostat (suberoylanilide hydroxamic acid) combined with cytarabine and etoposide in patients with relapsed, refractory, or high-risk acute myeloid leukemia
Ivana Gojo, Ming Tan, Hong-Bin Fang, et al.
British Journal of Haematology
|
December 6, 2019
Peripheral blood blast rate of clearance is an independent predictor of clinical response and outcomes in acute myeloid leukaemia
Noa G Holtzman, Firas El Chaer, Maria R Baer, et al.
Annals of Hematology
|
October 10, 2025
Impact of clinical response and treatment tolerability on HRQoL in newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia patients treated with ponatinib or imatinib
Ajibade Ashaye, Ling Shi, Ibrahim Aldoss, et al.
Biology
|
June 24, 2022
Impact of <i>FLT3</i>-ITD Insertion Length on Outcomes in Acute Myeloid Leukemia: A Propensity Score-Adjusted Cohort Study
Elizabeth M Corley, Moaath K Mustafa Ali, Hanan Alharthy, et al.
Mycopathologia
|
March 17, 2005
Invasive filamentous fungal infections in allogeneic hematopoietic stem cell transplant recipients after recovery from neutropenia: clinical, radiologic, and pathologic characteristics
Aasma Shaukat, Faris Bakri, Paul Young, et al.
Page
of 63
Search research articles
Search
Showing results (451-460 of 628) with videos related to
Sort By:
Page
of 63
Bone Marrow Transplantation
|
July 3, 2003
Use of nonvolume-reduced (unmanipulated after thawing) umbilical cord blood stem cells for allogeneic transplantation results in safe engraftment
T Hahn, U Bunworasate, M C George, et al.
Acta Haematologica
|
January 30, 2019
Relapsed Philadelphia Chromosome-Positive Pre-B-ALL after CD19-Directed CAR-T Cell Therapy Successfully Treated with Combination of Blinatumomab and Ponatinib
Firas El Chaer, Noa G Holtzman, Edward A Sausville, et al.
Blood Advances
|
July 16, 2025
Olutasidenib alone or combined with azacitidine in patients with mutant IDH1 myelodysplastic syndrome
Jorge E Cortes, Jay Yang, Gail J Roboz, et al.
Biomolecules
|
January 8, 2025
Rapid Detection of <i>PML::RARA</i> Fusions in Acute Promyelocytic Leukemia: CRISPR/Cas9 Nanopore Sequencing with Adaptive Sampling
William Middlezong, Victoria Stinnett, Michael Phan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 30, 1999
Patients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered
J C Byrd, R K Dodge, A Carroll, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 14, 2013
Translational phase I trial of vorinostat (suberoylanilide hydroxamic acid) combined with cytarabine and etoposide in patients with relapsed, refractory, or high-risk acute myeloid leukemia
Ivana Gojo, Ming Tan, Hong-Bin Fang, et al.
British Journal of Haematology
|
December 6, 2019
Peripheral blood blast rate of clearance is an independent predictor of clinical response and outcomes in acute myeloid leukaemia
Noa G Holtzman, Firas El Chaer, Maria R Baer, et al.
Annals of Hematology
|
October 10, 2025
Impact of clinical response and treatment tolerability on HRQoL in newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia patients treated with ponatinib or imatinib
Ajibade Ashaye, Ling Shi, Ibrahim Aldoss, et al.
Biology
|
June 24, 2022
Impact of <i>FLT3</i>-ITD Insertion Length on Outcomes in Acute Myeloid Leukemia: A Propensity Score-Adjusted Cohort Study
Elizabeth M Corley, Moaath K Mustafa Ali, Hanan Alharthy, et al.
Mycopathologia
|
March 17, 2005
Invasive filamentous fungal infections in allogeneic hematopoietic stem cell transplant recipients after recovery from neutropenia: clinical, radiologic, and pathologic characteristics
Aasma Shaukat, Faris Bakri, Paul Young, et al.
Page
of 63